Vault-13

REVANCE THERAPEUTICS INC RVNC

COM · Common Stock · CUSIP 761330109 · ISIN US7613301099

2 institutional holders -172 vs Q4 2024
86,10086.1k shares reported held*
$425.0kreported value*
0 new 0 added 0 reduced 165 sold out net sold ≈ $375.3m (-76.0m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.94.

Trends to Q1 2025

Institutional holders

Managers reporting a position, each quarter

0100200300Q3 22: 182Q4 22: 193Q1 23: 218Q2 23: 216Q3 23: 188Q4 23: 194Q1 24: 188Q2 24: 173Q3 24: 201Q4 24: 174Q1 25: 22Q3 22Q1 23Q3 23Q1 24Q3 24Q1 25
Numbers
QuarterHolders
Q3 2022182
Q4 2022193
Q1 2023218
Q2 2023216
Q3 2023188
Q4 2023194
Q1 2024188
Q2 2024173
Q3 2024201
Q4 2024174
Q1 20252

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
2000200Q2 23: 123 bought or addedQ2 23: 100 cut or sold outQ3 23: 104 bought or addedQ3 23: 95 cut or sold outQ3 23Q4 23: 105 bought or addedQ4 23: 83 cut or sold outQ1 24: 99 bought or addedQ1 24: 94 cut or sold outQ1 24Q2 24: 87 bought or addedQ2 24: 83 cut or sold outQ3 24: 107 bought or addedQ3 24: 97 cut or sold outQ3 24Q4 24: 84 bought or addedQ4 24: 108 cut or sold outQ1 25: 0 bought or addedQ1 25: 165 cut or sold outQ1 25
Numbers
QuarterBought or addedCut or sold out
Q2 2023123100
Q3 202310495
Q4 202310583
Q1 20249994
Q2 20248783
Q3 202410797
Q4 202484108
Q1 20250165

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$5m$10m$15m$20mQ2 24 calls: $1.6mQ2 24 puts: $774.9kQ2 24P/C 0.49Q3 24 calls: $4.4mQ3 24 puts: $5.3mQ3 24P/C 1.21Q4 24 calls: $15.0mQ4 24 puts: $17.3mQ4 24P/C 1.15Q1 25 calls: $0Q1 25 puts: $0Q1 25P/C —
Numbers
QuarterCallsPutsP/C
Q2 2024$1.6m$774.9k0.49
Q3 2024$4.4m$5.3m1.21
Q4 2024$15.0m$17.3m1.15
Q1 2025$0$0—

Biggest buyers

None

Biggest sellers

BlackRock, Inc. Sold out -8,597,418-8.6m
Beryl Capital Management LLC Sold out -5,935,009-5.9m
VANGUARD GROUP INC Sold out -5,625,091-5.6m
FIL Ltd Sold out -4,196,095-4.2m
ALLIANCEBERNSTEIN L.P. Sold out -3,497,112-3.5m
Squarepoint Ops LLC Sold out -3,164,943-3.2m
Magnetar Financial LLC Sold out -2,556,345-2.6m
STATE STREET CORP Sold out -2,439,140-2.4m
ALPINE ASSOCIATES MANAGEMENT INC. Sold out -2,349,966-2.3m
GEODE CAPITAL MANAGEMENT, LLC Sold out -2,297,582-2.3m

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Teoxane SA 13D · may seek influence no change · filed 2025-01-30
Stated purposeOn December 9, 2024, the Issuer announced its entry into an Amended and Restated Agreement and Plan of Merger (as amended by Amendment, dated December 11, 2024, the "A&R Merger Agreement") with Crown Laboratories, Inc. and Reb Merger Sub, Inc. (collectively, "Crown"), pursuant to which Crown commenced a tender offer (the "Tender Offer") on December 12, 2024 to purchase all of the outstanding shares of Common Stock at a price of $3.10 per share (such price, the "Offer Price"). On January 6, 2025, the Reporting Person submitted a proposal (the "Proposal") to the chairman of the board of directors and the chief executive officer of the Issuer proposing a transaction (the "Proposed Transaction") pursuant to which the Reporting Person would purchase all of the outstanding shares of Common Stoc… Full filing
 6.2% no change 6.6m 2025-01-30

Holders, Q1 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 DekaBank Deutsche Girozentrale 0.00% of their portfolio FRANKFURT, 2M 86,10086.1k $425.0k $425.0k 0.00% Unchanged
2 IFP Advisors, Inc 0.00% of their portfolio TAMPA, FL 00 $44 $44 0.00% Unchanged